Unknown PHASE2 INTERVENTIONAL 3-arm NCT03968042

Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Interventions Combination of vitamin B1, B6, C, E and mecobalamine Edaravone Nerve Growth Factor

Updated 6 times since 2019 Last updated: Oct 24, 2020 Started: Jun 30, 2019 Primary completion: Dec 31, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03968042, this PHASE2 trial focuses on Alcohol-induced Brain Injury and remains ongoing. Sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Recruiting PHASE2
Nov 2020 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jun 2019 — Nov 2020 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Data source: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China